What's New
Last Posted: Sep 13, 2020
- Cancer Projects to Diversify Genetic Research Receive New Grants
E Goldberg, NY Times, September 11, 2020 - Racial Differences in Genomic Profiling of Prostate Cancer.
Mahal Brandon A et al. The New England journal of medicine 2020 Sep (11) 1083-1085 - Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
SB Ye, NPJ Precision Oncology, September 8, 2020 - Refining risk-estimates in HNPCC: are we there yet?
PM ynch et al, JNCI Cancer Spectrum, 2020 - Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program.
White Randie E et al. The breast journal 2020 Sep - Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working Group.
Godsey James H et al. Clinical chemistry 2020 Sep 66(9) 1156-1166 - Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values.
Costa Sarah et al. The patient 2020 Sep - Health Insurance Coverage Disruptions among Cancer Survivors and Access to Care and Affordability in the United States.
Zhao Jingxuan et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Aug - Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.
Shah Anand et al. Journal of general internal medicine 2020 Sep - Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Integration Sites and Involvement of the KMT2D Tumor Suppressor Gene.
Arora Reety et al. Viruses 2020 Aug 12(9) - T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Shiradkar Rakesh et al. European radiology 2020 Sep - The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis.
Zhang Wei et al. Medicine 2020 Aug 99(33) e21483 - Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu Michael T et al. Annals of internal medicine 2020 Sep - Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Dummer Reinhard et al. The New England journal of medicine 2020 Sep - Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450
V Hlavac et al, J Per Med, August 2020
.png)
No hay comentarios:
Publicar un comentario